![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: TRMT2B |
Gene summary for TRMT2B |
![]() |
Gene information | Species | Human | Gene symbol | TRMT2B | Gene ID | 79979 |
Gene name | tRNA methyltransferase 2 homolog B | |
Gene Alias | CXorf34 | |
Cytomap | Xq22.1 | |
Gene Type | protein-coding | GO ID | GO:0001510 | UniProtAcc | A0A024RCF5 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
79979 | TRMT2B | HCC2_Meng | Human | Liver | HCC | 1.49e-07 | 5.52e-02 | 0.0107 |
79979 | TRMT2B | HCC1 | Human | Liver | HCC | 5.61e-06 | 9.09e-01 | 0.5336 |
79979 | TRMT2B | HCC2 | Human | Liver | HCC | 6.22e-15 | 1.65e+00 | 0.5341 |
79979 | TRMT2B | HCC5 | Human | Liver | HCC | 1.31e-13 | 1.47e+00 | 0.4932 |
79979 | TRMT2B | S028 | Human | Liver | HCC | 1.10e-06 | 2.97e-01 | 0.2503 |
79979 | TRMT2B | S029 | Human | Liver | HCC | 3.47e-03 | 2.12e-01 | 0.2581 |
Page: 1 |
![]() |
Tissue | Expression Dynamics | Abbreviation |
Liver | ![]() | HCC: Hepatocellular carcinoma |
NAFLD: Non-alcoholic fatty liver disease |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:00344702 | Liver | HCC | ncRNA processing | 293/7958 | 395/18723 | 4.26e-38 | 6.76e-35 | 293 |
GO:00346601 | Liver | HCC | ncRNA metabolic process | 332/7958 | 485/18723 | 1.48e-31 | 7.80e-29 | 332 |
GO:0008033 | Liver | HCC | tRNA processing | 87/7958 | 127/18723 | 2.66e-09 | 7.23e-08 | 87 |
GO:00434141 | Liver | HCC | macromolecule methylation | 183/7958 | 316/18723 | 2.00e-08 | 4.72e-07 | 183 |
GO:0032259 | Liver | HCC | methylation | 206/7958 | 364/18723 | 3.35e-08 | 7.53e-07 | 206 |
GO:0006399 | Liver | HCC | tRNA metabolic process | 108/7958 | 179/18723 | 1.07e-06 | 1.59e-05 | 108 |
GO:0009451 | Liver | HCC | RNA modification | 101/7958 | 167/18723 | 2.02e-06 | 2.78e-05 | 101 |
GO:0006400 | Liver | HCC | tRNA modification | 60/7958 | 90/18723 | 3.09e-06 | 4.09e-05 | 60 |
GO:0001510 | Liver | HCC | RNA methylation | 53/7958 | 83/18723 | 6.96e-05 | 6.29e-04 | 53 |
GO:0030488 | Liver | HCC | tRNA methylation | 29/7958 | 41/18723 | 2.38e-04 | 1.79e-03 | 29 |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
TRMT2B | insertion | Frame_Shift_Ins | novel | c.965dupT | p.Gln323ProfsTer3 | p.Q323Pfs*3 | Q96GJ1 | protein_coding | TCGA-B5-A3FC-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | ||
TRMT2B | insertion | Frame_Shift_Ins | novel | c.1170_1171insGAATGGCTTGA | p.Ile391GlufsTer23 | p.I391Efs*23 | Q96GJ1 | protein_coding | TCGA-BG-A0MS-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | carboplatin | SD | ||
TRMT2B | insertion | Frame_Shift_Ins | novel | c.578_579insA | p.Asn193LysfsTer4 | p.N193Kfs*4 | Q96GJ1 | protein_coding | TCGA-PG-A6IB-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | ||
TRMT2B | SNV | Missense_Mutation | c.709N>A | p.Gly237Arg | p.G237R | Q96GJ1 | protein_coding | tolerated(0.07) | possibly_damaging(0.635) | TCGA-44-2656-01 | Lung | lung adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | PD | |
TRMT2B | SNV | Missense_Mutation | c.879N>T | p.Gln293His | p.Q293H | Q96GJ1 | protein_coding | deleterious(0.01) | benign(0.1) | TCGA-49-AARE-01 | Lung | lung adenocarcinoma | Female | <65 | I/II | Unknown | Unknown | PD | |
TRMT2B | SNV | Missense_Mutation | novel | c.1214N>C | p.Leu405Ser | p.L405S | Q96GJ1 | protein_coding | deleterious(0.03) | possibly_damaging(0.908) | TCGA-55-8506-01 | Lung | lung adenocarcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
TRMT2B | SNV | Missense_Mutation | novel | c.374N>T | p.Ser125Ile | p.S125I | Q96GJ1 | protein_coding | tolerated(0.19) | benign(0.003) | TCGA-55-8506-01 | Lung | lung adenocarcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
TRMT2B | SNV | Missense_Mutation | c.1364N>T | p.Gly455Val | p.G455V | Q96GJ1 | protein_coding | deleterious(0) | possibly_damaging(0.593) | TCGA-55-A493-01 | Lung | lung adenocarcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
TRMT2B | SNV | Missense_Mutation | c.1323N>C | p.Arg441Ser | p.R441S | Q96GJ1 | protein_coding | tolerated(0.23) | benign(0.007) | TCGA-69-7979-01 | Lung | lung adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
TRMT2B | SNV | Missense_Mutation | rs768238349 | c.1334C>T | p.Thr445Met | p.T445M | Q96GJ1 | protein_coding | deleterious(0.01) | possibly_damaging(0.601) | TCGA-75-6205-01 | Lung | lung adenocarcinoma | Female | Unknown | I/II | Unknown | Unknown | PD |
Page: 1 2 3 4 5 6 7 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |